About Miedzyleski Szpital Specjalistyczny w Warszawie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
5
Hoffmann-La Roche
3
Pfizer
2
Bavarian Nordic
1
Biogen
1
Chimerix
1
Chinook Therapeutics U.S., Inc.
1
Cogentus Pharmaceuticals
1
Gilead Sciences
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Clinical Trials at Miedzyleski Szpital Specjalistyczny w Warszawie
During the past decade, Miedzyleski Szpital Specjalistyczny w Warszawie conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
2007-01-01
2012-01-01
Completed
1,445
A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD
2007-04-01
2009-10-01
Terminated
158
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
2010-12-01
2013-08-01
Completed
256
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
2011-11-28
2017-12-15
Completed
1,297
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
2011-11-01
2013-10-01
Completed
465
An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)
2013-03-28
2018-09-04
Completed
225
Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
2014-08-05
2022-01-31
Completed
95
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Miedzyleski Szpital Specjalistyczny w Warszawie" #1 sponsor was "Shire" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "Pfizer" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Biogen"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Miedzyleski Szpital Specjalistyczny w Warszawie"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Miedzyleski Szpital Specjalistyczny w Warszawie
According to Clinical.Site data, the most researched conditions in "Miedzyleski Szpital Specjalistyczny w Warszawie" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Acute Coronary Syndrome" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Miedzyleski Szpital Specjalistyczny w Warszawie" in a lesser frequency.
Clinical Trials Intervention Types at Miedzyleski Szpital Specjalistyczny w Warszawie
Most popular intervention types in "Miedzyleski Szpital Specjalistyczny w Warszawie" are "Drug" (16 trials), "Other" (5 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Ontamalimab" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Atrasentan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Miedzyleski Szpital Specjalistyczny w Warszawie
The vast majority of trials in "Miedzyleski Szpital Specjalistyczny w Warszawie" are
16 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Miedzyleski Szpital Specjalistyczny w Warszawie
Currently, there are NaN active trials in "Miedzyleski Szpital Specjalistyczny w Warszawie".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Miedzyleski Szpital Specjalistyczny w Warszawie,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Miedzyleski Szpital Specjalistyczny w Warszawie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".